Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of bioglutide na931 powder in China. We warmly welcome yuo to wholesale bulk bioglutide na931 powder for sale here from our factory. Quality products and reasonable price are available.
NA-931 (Bioglutide)
Bioglutide NA931 powder is an innovative metabolic drug currently in clinical development, primarily for the treatment of metabolic diseases such as obesity and type 2 diabetes. It represents a new generation of drug design thinking, known as "poly-agonists," which achieve stronger, more comprehensive therapeutic effects than traditional single-target drugs by simultaneously targeting multiple key metabolic pathways. In the current drug development path, weight-loss drugs have gradually evolved from single-target to multi-target. For example, early drugs focused on the GLP-1 single pathway, followed by dual agonists that act on both GLP-1 and GIP, and then by further candidates expanding to triple agonists (GLP-1, GIP, and glucagon). Bioglutide goes a step further, introducing a fourth pathway related to muscle metabolism, aiming to optimize body composition while reducing fat, which is one of the key reasons it is considered a "next-generation weight-loss therapy." If you are also interested and seeking a NA 931 manufacturer, please feel free to contact Xi'an Sonwu.

Certificate Of Analysis
|
Item |
Enterprise standard |
Test result |
|
Appearance |
White fine powder |
White powder |
|
Water content |
≤5.0% |
0.38% |
|
Loss on drying |
≤1.0% |
0.26% |
|
Acetate content |
≤12.0% |
Confirm |
|
Moisture conten |
≤8.0% |
Confirm |
|
Peptide content |
≥80.0% |
Confirm |
|
Amino acid composition analysis |
≤±10% |
Confirm |
|
Purity (HPLC) |
≥99.0% |
99.90% |
|
Single impurity |
<0.8% |
0.39% |
|
Total microbial count |
≤750cfu/g |
80 |
|
E. Coli |
≤2MPN/g |
Confirm |
|
Salmonella |
N.D. |
Confirm |
|
Ethanol (by GC) |
≤5000ppm |
400ppm |
Bioglutide Buy Online
Xi'an Sonwu Biotech Co. ltd. has rich experience in global trade and the health industry. Insist on faith-based and quality-first principles; they are our company's principles. Xi'an Sonwu strictly controls product quality, meaning selection starts with raw materials. Besides, Xi'an Sonwu handles every detail and minimizes costs to ensure customers receive a cost-effective product. Based on this, customers have given very positive feedback on the products. So look for Xi'an Sonwu Biotech Co. ltd. when buying NA-931.
Xi'an Sonwu ensures the product's quality so that samples can be supplied. Here is the quantity.
|
Form |
Sample Amount |
The Minimum Of Quantity |
|
Powder |
1g |
10g |
|
Bulk capsules |
1000 capsule |
1000 capsule |
|
Bottle capsules |
20 bottles |
20 bottle |
Customers' Good Comment

OEM Service
Xi'an Sonwu not only supplies high-quality pure powder but also capsules.
So customers can customize the capsules they want. And also offer the following items.
1. Customized capsule shells (size, color, material)
2. Customized bottles(size, color, material, style)
3. Customized packaging(vacuum foil packaging, box, drum)
4. Customized label(paint film, matte film, optical mask)
What Is The Mechanism Of Action Of NA-931
NA-931 is a typical multi-receptor agonist. Its core characteristic is its ability to simultaneously act on multiple metabolism-related receptors, rather than targeting a single pathway. Through this multi-target synergistic activation, NA-931 can produce synergistic effects in multiple physiological systems. For example, on the one hand, it suppresses appetite and reduces energy intake; on the other hand, it increases basal metabolic rate and promotes lipolysis, while simultaneously improving insulin secretion and sensitivity and, to some extent, protecting lean body mass. This "multidimensional regulation" is the essence of its mechanism.
1. GLP-1 Receptor – A Core Pathway for Appetite and Glucose Regulation
The glucagon-like peptide-1 receptor is a key target of NA-931 and one of the most well-established mechanisms of action in current weight-loss drugs. NA-931 activates the GLP-1 receptor and acts in the central nervous system (especially the hypothalamus) to suppress the appetite center, thereby reducing eating behavior. Simultaneously, it can delay gastric emptying, allowing food to remain in the stomach longer and enhancing satiety. Furthermore, GLP-1 can promote insulin secretion from pancreatic β-cells under hyperglycemic conditions and inhibit glucagon secretion, thereby lowering blood glucose levels. The combined effect of this pathway is to reduce calorie intake, stabilize blood glucose fluctuations, and improve postprandial metabolic status. This mechanism is fundamental for obese patients and those with type 2 diabetes.
2. GIP Receptor – Synergistic Enhancement of Pancreatic Function and Metabolism
Glucose-dependent insulinotropic peptide receptor (GIP) is the second important target of NA-931. GIP also belongs to the incretin system and promotes insulin secretion after glucose ingestion. Unlike GLP-1, GIP also has certain functions in adipose tissue, bone, and the central nervous system. After NA-931 activates the GIP receptor, it can enhance pancreatic β-cell responsiveness to changes in blood glucose, improve insulin secretion efficiency, and reduce insulin resistance to some extent. In addition, the combined activation of GIP and GLP-1 can produce a synergistic effect, thereby stabilizing blood glucose control. This "dual incretin" mechanism has been shown to confer beneficial metabolic effects when combined with other drugs.

3. Glucagon Receptor – Energy Expenditure and Lipolysis Pathway
Activation of the glucagon receptor is one of the key mechanisms that distinguishes NA-931 from some traditional drugs. Glucagon is generally considered a hormone that raises blood glucose, but in metabolic regulation, it also promotes lipolysis and increases energy expenditure. NA-931, by moderately activating this receptor, can promote lipolysis in adipose tissue, mobilizing stored fat for usable energy. Simultaneously, it can increase the basal metabolic rate, allowing the body to consume more energy at rest. Furthermore, in the liver, glucagon can promote glucose output, but this effect is usually partially offset by the combined regulation of GLP-1 and GIP, thereby avoiding significant hyperglycemia. The core significance of this pathway lies not only in reducing intake but also in increasing expenditure, thereby creating a "negative energy balance."
4. IGF-1 Related Pathway – Lean Body Protection Mechanism
A relatively unique aspect of NA-931 is its potential involvement in the IGF-1 (insulin-like growth factor-1) related pathway. IGF-1 plays a crucial role in muscle growth and protein synthesis. By regulating this pathway, NA-931 holds promise for reducing muscle loss during weight loss. Specifically, activation of the IGF-1 pathway can promote muscle protein synthesis, inhibit protein breakdown, and support skeletal muscle maintenance. This means that while weight decreases, body composition may be better optimized, with a decrease in fat percentage and a relative retention of lean body mass, thereby having a long-term positive impact on basal metabolic rate.
5. Multi-Target Synergistic Mechanism
The real advantage of NA-931 lies in the synergistic effect between the aforementioned multiple pathways, rather than a simple superposition of single targets.
GLP-1 suppresses appetite and reduces calorie intake.
Glucagon increases energy expenditure and promotes fat burning.
GLP and GLP-1 synergistically improve insulin secretion and glycemic control.
The IGF-1 pathway helps maintain muscle mass.
This combination allows the body to "eat less" while "burning more," and minimizes metabolic adaptation decline (such as metabolic slowdown due to muscle loss). From a systems biology perspective, this represents multi-node regulation of the energy balance network.

NA-931 VS Retatrutide
Bioglutide NA931 powder and Retatrutide are two cutting-edge candidates in the field of weight loss and metabolic drugs. While they share significant similarities in their mechanism design, they differ significantly in molecular type, depth of action, and clinical maturity.
NA-931 is more like a new generation of "oral route explorer," while Retatrutide is closer to a "mature candidate" for practical application. Both are based on the concept of "multi-receptor agonism," simultaneously regulating multiple metabolic pathways: GLP-1 → suppressing appetite and delaying gastric emptying; GIP → enhancing insulin secretion; and glucagon → increasing energy expenditure and promoting lipolysis. However, the key difference lies in NA-931's additional mechanism. NA-931 adds the IGF-1-related pathway to the above, with potential effects including increased protein synthesis, reduced muscle breakdown, and maintenance of lean body mass. While Retatrutide has only three targets, it exhibits stronger activation of the glucagon receptor, resulting in a more pronounced overall metabolic stimulation.
Factory
1. Xi'an Sonwu Biotech Co., Ltd has its factory to produce, manufacture and store the products, so have adequate stock. Xi'an Sonwu has a well-ordered, clean and tidy production department. Under Xi'an Sonwu, researchers can continuously develop high-quality new products.
2. Xi'an Sonwu has strict requirements on personnel allocation from production and testing to sales. To ensure that each product is escorted, rigorous data support and after-sales service are provided.


Certificates

Packaging

Logistics

Besides guaranteeing the product, the other most important thing is that customers can receive the goods smoothly. So, Xi'an Sonwu offers a range of couriers to meet different needs.

FAQ
Overall, Bioglutide (NA-931) represents a cutting-edge research direction in the treatment of metabolic diseases, namely, achieving more efficient and comprehensive weight and metabolic management through multi-pathway synergistic regulation. It combines multiple potential advantages, including appetite suppression, improved blood glucose, increased fat burning, and muscle protection. It has shown strong weight loss effects and certain safety signals in early studies. However, it still requires larger-scale, longer-term clinical validation before it can become a clinically available drug.
If you want to know the NA 931 price, you can contact Xi'an Sonwu. Click the email, and then you get high-quality bioglutide NA931 powder.
Email: sales@sonwu.com
Hot Tags: bioglutide na931 powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, BPC157 Powder, KPV powder, PT 141 Powder, Retatrutide Powder, Slu PP 332 peptide powder, SLU PP 332 Powder
















